CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Quidelortho Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Quidelortho Corp
9975 Summers Ridge Road,
Phone: (858) 552-1100p:858 552-1100 SAN DIEGO, CA  92121  United States Ticker: QDELQDEL
Business Summary
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/29/202412/31/2023YesYes--Yes

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8071 Medical laboratories
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Kenneth F.Buechler 70 12/1/2022 11/6/2007
President, Chief Executive Officer, Director Brian J.Blaser 5/15/2024 5/6/2024
Chief Financial Officer Joseph M.Busky 56 5/27/2022 5/27/2022
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Quidel Corporation File 50177 Los Angeles CA United States
Ortho Clinical Diagnostics Holdings plc 1001 Route 202 RARITAN NJ United States
Diagnostic Hybrids, Inc. 2005 East State St., Suite 100 Athens OH United States

Business Names
Business Name
10165 McKellar Court, L.P.
AdenoPlus®
BioHelix Corporation
78 additional Business Names available in full report.

General Information
Number of Employees: 7,100 (As of 12/31/2023)
Outstanding Shares: 67,256,717 (As of 10/30/2024)
Shareholders: 88
Stock Exchange: NASD
Federal Tax Id: 942573850
Fax Number: (858) 453-4338
Email Address: ir@quidel.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024